Global Carbetocin Acetate 麻豆原创 Research Report 2023

Publication ID:

PB504244221

Publication Date:

May 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Carbetocin Acetate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Carbetocin Acetate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Carbetocin Acetate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Carbetocin Acetate in Oxytocic is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Carbetocin Acetate include Beacon Pharmaceuticals Limited, Ferring Inc., Polypeptide Laboraries France, Chemos GmbH & Co. KG, Hangzhou Dayangchem Co. Ltd., Acinopeptide Co., Ltd., Bachem AG, Clearsynth Canada INC. and Leap Labchem Co., Ltd, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Carbetocin Acetate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbetocin Acetate.
The Carbetocin Acetate market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Carbetocin Acetate market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbetocin Acetate companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Beacon Pharmaceuticals Limited
Ferring Inc.
Polypeptide Laboraries France
Chemos GmbH & Co. KG
Hangzhou Dayangchem Co. Ltd.
Acinopeptide Co., Ltd.
Bachem AG
Clearsynth Canada INC.
Leap Labchem Co., Ltd
Chemieliva Pharmaceutical Co., Ltd.
BOC Sciences
Chengdu Shengnuo Biopharmaceutical
Hybio Pharmaceutical
Segment by Type
Tablets
Injection
Segment by Application
Oxytocic
Antihemorrhagic
Uterotonic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Carbetocin Acetate companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Carbetocin Acetate 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tablets
1.2.3 Injection
1.3 麻豆原创 by Application
1.3.1 Global Carbetocin Acetate 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oxytocic
1.3.3 Antihemorrhagic
1.3.4 Uterotonic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Carbetocin Acetate 麻豆原创 Perspective (2018-2029)
2.2 Carbetocin Acetate Growth Trends by Region
2.2.1 Global Carbetocin Acetate 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Carbetocin Acetate Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Carbetocin Acetate Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Carbetocin Acetate 麻豆原创 Dynamics
2.3.1 Carbetocin Acetate Industry Trends
2.3.2 Carbetocin Acetate 麻豆原创 Drivers
2.3.3 Carbetocin Acetate 麻豆原创 Challenges
2.3.4 Carbetocin Acetate 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carbetocin Acetate Players by Revenue
3.1.1 Global Top Carbetocin Acetate Players by Revenue (2018-2023)
3.1.2 Global Carbetocin Acetate Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Carbetocin Acetate 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Carbetocin Acetate Revenue
3.4 Global Carbetocin Acetate 麻豆原创 Concentration Ratio
3.4.1 Global Carbetocin Acetate 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carbetocin Acetate Revenue in 2022
3.5 Carbetocin Acetate Key Players Head office and Area Served
3.6 Key Players Carbetocin Acetate Product Solution and Service
3.7 Date of Enter into Carbetocin Acetate 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Carbetocin Acetate Breakdown Data by Type
4.1 Global Carbetocin Acetate Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Carbetocin Acetate Forecasted 麻豆原创 Size by Type (2024-2029)
5 Carbetocin Acetate Breakdown Data by Application
5.1 Global Carbetocin Acetate Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Carbetocin Acetate Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Carbetocin Acetate 麻豆原创 Size (2018-2029)
6.2 North America Carbetocin Acetate 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Carbetocin Acetate 麻豆原创 Size by Country (2018-2023)
6.4 North America Carbetocin Acetate 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Carbetocin Acetate 麻豆原创 Size (2018-2029)
7.2 Europe Carbetocin Acetate 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Carbetocin Acetate 麻豆原创 Size by Country (2018-2023)
7.4 Europe Carbetocin Acetate 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Carbetocin Acetate 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Carbetocin Acetate 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Carbetocin Acetate 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Carbetocin Acetate 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Carbetocin Acetate 麻豆原创 Size (2018-2029)
9.2 Latin America Carbetocin Acetate 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Carbetocin Acetate 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Carbetocin Acetate 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carbetocin Acetate 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Carbetocin Acetate 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Carbetocin Acetate 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Carbetocin Acetate 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Beacon Pharmaceuticals Limited
11.1.1 Beacon Pharmaceuticals Limited Company Detail
11.1.2 Beacon Pharmaceuticals Limited Business Overview
11.1.3 Beacon Pharmaceuticals Limited Carbetocin Acetate Introduction
11.1.4 Beacon Pharmaceuticals Limited Revenue in Carbetocin Acetate Business (2018-2023)
11.1.5 Beacon Pharmaceuticals Limited Recent Development
11.2 Ferring Inc.
11.2.1 Ferring Inc. Company Detail
11.2.2 Ferring Inc. Business Overview
11.2.3 Ferring Inc. Carbetocin Acetate Introduction
11.2.4 Ferring Inc. Revenue in Carbetocin Acetate Business (2018-2023)
11.2.5 Ferring Inc. Recent Development
11.3 Polypeptide Laboraries France
11.3.1 Polypeptide Laboraries France Company Detail
11.3.2 Polypeptide Laboraries France Business Overview
11.3.3 Polypeptide Laboraries France Carbetocin Acetate Introduction
11.3.4 Polypeptide Laboraries France Revenue in Carbetocin Acetate Business (2018-2023)
11.3.5 Polypeptide Laboraries France Recent Development
11.4 Chemos GmbH & Co. KG
11.4.1 Chemos GmbH & Co. KG Company Detail
11.4.2 Chemos GmbH & Co. KG Business Overview
11.4.3 Chemos GmbH & Co. KG Carbetocin Acetate Introduction
11.4.4 Chemos GmbH & Co. KG Revenue in Carbetocin Acetate Business (2018-2023)
11.4.5 Chemos GmbH & Co. KG Recent Development
11.5 Hangzhou Dayangchem Co. Ltd.
11.5.1 Hangzhou Dayangchem Co. Ltd. Company Detail
11.5.2 Hangzhou Dayangchem Co. Ltd. Business Overview
11.5.3 Hangzhou Dayangchem Co. Ltd. Carbetocin Acetate Introduction
11.5.4 Hangzhou Dayangchem Co. Ltd. Revenue in Carbetocin Acetate Business (2018-2023)
11.5.5 Hangzhou Dayangchem Co. Ltd. Recent Development
11.6 Acinopeptide Co., Ltd.
11.6.1 Acinopeptide Co., Ltd. Company Detail
11.6.2 Acinopeptide Co., Ltd. Business Overview
11.6.3 Acinopeptide Co., Ltd. Carbetocin Acetate Introduction
11.6.4 Acinopeptide Co., Ltd. Revenue in Carbetocin Acetate Business (2018-2023)
11.6.5 Acinopeptide Co., Ltd. Recent Development
11.7 Bachem AG
11.7.1 Bachem AG Company Detail
11.7.2 Bachem AG Business Overview
11.7.3 Bachem AG Carbetocin Acetate Introduction
11.7.4 Bachem AG Revenue in Carbetocin Acetate Business (2018-2023)
11.7.5 Bachem AG Recent Development
11.8 Clearsynth Canada INC.
11.8.1 Clearsynth Canada INC. Company Detail
11.8.2 Clearsynth Canada INC. Business Overview
11.8.3 Clearsynth Canada INC. Carbetocin Acetate Introduction
11.8.4 Clearsynth Canada INC. Revenue in Carbetocin Acetate Business (2018-2023)
11.8.5 Clearsynth Canada INC. Recent Development
11.9 Leap Labchem Co., Ltd
11.9.1 Leap Labchem Co., Ltd Company Detail
11.9.2 Leap Labchem Co., Ltd Business Overview
11.9.3 Leap Labchem Co., Ltd Carbetocin Acetate Introduction
11.9.4 Leap Labchem Co., Ltd Revenue in Carbetocin Acetate Business (2018-2023)
11.9.5 Leap Labchem Co., Ltd Recent Development
11.10 Chemieliva Pharmaceutical Co., Ltd.
11.10.1 Chemieliva Pharmaceutical Co., Ltd. Company Detail
11.10.2 Chemieliva Pharmaceutical Co., Ltd. Business Overview
11.10.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin Acetate Introduction
11.10.4 Chemieliva Pharmaceutical Co., Ltd. Revenue in Carbetocin Acetate Business (2018-2023)
11.10.5 Chemieliva Pharmaceutical Co., Ltd. Recent Development
11.11 BOC Sciences
11.11.1 BOC Sciences Company Detail
11.11.2 BOC Sciences Business Overview
11.11.3 BOC Sciences Carbetocin Acetate Introduction
11.11.4 BOC Sciences Revenue in Carbetocin Acetate Business (2018-2023)
11.11.5 BOC Sciences Recent Development
11.12 Chengdu Shengnuo Biopharmaceutical
11.12.1 Chengdu Shengnuo Biopharmaceutical Company Detail
11.12.2 Chengdu Shengnuo Biopharmaceutical Business Overview
11.12.3 Chengdu Shengnuo Biopharmaceutical Carbetocin Acetate Introduction
11.12.4 Chengdu Shengnuo Biopharmaceutical Revenue in Carbetocin Acetate Business (2018-2023)
11.12.5 Chengdu Shengnuo Biopharmaceutical Recent Development
11.13 Hybio Pharmaceutical
11.13.1 Hybio Pharmaceutical Company Detail
11.13.2 Hybio Pharmaceutical Business Overview
11.13.3 Hybio Pharmaceutical Carbetocin Acetate Introduction
11.13.4 Hybio Pharmaceutical Revenue in Carbetocin Acetate Business (2018-2023)
11.13.5 Hybio Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Beacon Pharmaceuticals Limited
Ferring Inc.
Polypeptide Laboraries France
Chemos GmbH & Co. KG
Hangzhou Dayangchem Co. Ltd.
Acinopeptide Co., Ltd.
Bachem AG
Clearsynth Canada INC.
Leap Labchem Co., Ltd
Chemieliva Pharmaceutical Co., Ltd.
BOC Sciences
Chengdu Shengnuo Biopharmaceutical
Hybio Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.